Target intelligence / Profile preview

Klebsiella pneumoniae cell wall (null)

Target
null
Molecular classification
Other (Bacterial cell envelope structure)
01

Overview

**The Klebsiella pneumoniae cell wall is a rigid, multilayered structure that surrounds the bacterial cell, composed primarily of a thin peptidoglycan layer and an outer membrane rich in lipopolysaccharide and other polysaccharides.** It plays essential roles in maintaining structural integrity, preventing osmotic lysis, and protecting the bacterium from host immune responses. The peptidoglycan consists of alternating units of N-acetyl-glucosamine and N-acetyl-muramic acid crosslinked by short peptides, while associated enzymes (like D-Ala-D-Ala carboxypeptidases) are critical in its biosynthesis and remodeling[1][4]. The cell wall is a principal target of many antibiotics—particularly beta-lactams and carbapenems—which inhibit peptidoglycan synthesis, leading to bacterial death[2][4]. Disruption of the cell wall (e.g., by molecular nanomachines or lytic enzymes) markedly increases the susceptibility of multidrug-resistant K. pneumoniae to antibiotics[2]. Cell wall architecture and associated mechanisms underlie K. pneumoniae’s notable multidrug resistance, as the outer membrane acts as a permeability barrier and is central to both the pathogen’s virulence and challenges in clinical therapy[5][4].

Other names
Bacterial cell wall (of Klebsiella pneumoniae)Cell wallK. pneumoniae cell wall
02

Mechanism of action

Inhibition of peptidoglycan biosynthesis (beta-lactams, carbapenems); Disruption/increase of cell wall permeability (by molecular nanomachines); Enzyme inhibition (e.g., D-Ala-D-Ala peptidases)

03

Biological functions

Structural integrityCell growth and divisionProtection against environmental stress and host defensesDetermines bacterial shape
04

Disease associations

InfectionAntibiotic resistance
05

Safety considerations

Emergence of multidrug resistanceOff-target toxicity with new agents disrupting bacterial and possibly eukaryotic membranesTherapeutic selectivity: risk that attacks on host flora can lead to dysbiosis
06

Interacting drugs

Beta-lactam antibiotics (e.g., meropenem, imipenem, cephalosporins)

3 more in the full profile.

07

Biomarkers

Capsule polysaccharide (for strain typing, not cell wall per se)Beta-lactamase production (as marker of cell wall-targeted drug resistance)

Beyond the preview

Go deeper on Klebsiella pneumoniae cell wall (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Klebsiella pneumoniae cell wall (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call